Yellow Fever: Adverse Reactions and Risks

undefined
YELLOW FEVER
WELL-DOCUMENTED ADVERSE REACTIONS
What’s the difference?
undefined
1 SEVERE
REACTION
Reported in 2016
Adverse reactions to general
vaccines:  0.13 per 100,000 doses
33 
anaphylaxis
 reports (25.1 million
doses)
Reaction time: 
immediately up to
the next day
Immediate Hypersensitivity or
Anaphylaxis
undefined
3 SEVERE
REACTIONS
Reported in 2010:
YF Serious adverse events: 4.7 per
100,000 doses distributed
0.8
1.8 
anaphylaxis
 per 100,000
doses
8.3 per 100,000 in 
˃60 years of age
Reaction time: ≤30 minutes up to
45 days
.
Immediate Hypersensitivity or
Anaphylaxis
YEL-AND   Vaccine-associated
neurotropic disease
YEL-AVD   Vaccine-associated
viscerotropic disease
undefined
VACCINE-
ASSOCIATED
NEUROTROPIC
DISEASE
Serious but rarely fatal
1990
–2006
29 cases of YF–AND
9 meningoencephalitis (neurotropic
disease) (5-24 days to onset)
8 Gullain
Barré
 
Syndrome (GBS) (7-27
days to onset)
3 Acute Disseminated Encephalomyelitis
(ADEM) (7-20 days to onset)
1 Bulbar palsy
8 insufficient data to classify
Symptom onset 3–28 
days
All cases reported in first-time
recipients
53 year old male:  fatality 9 days
post vax .   Undiagnosed HIV
56 year old male: longitudinal
myelitis.  
Onset 45 days post vax
YEL
AND:  0.4–0.8 per 100,000
˃
60 years =  1.6 per 100,000
˃
70 years = 1.1 to 2.3 per 100,000
undefined
VACCINE-
ASSOCIATED
VISCEROTROPIC
DISEASE
YEL-AVD first described in 2001
Febrile multiple organ system failure
that mimics naturally acquired YF
57 cases reported from 14 countries
as of Feb 2010.
Onset from vaccination 3 days (1-8
days)
Time from vaccination to death 10
days (7-30 days)
65% fatality
All cases reported in first-time
recipients
YEL-AVD: 0.3
0.4 per 100,000
doses
˃60 years 1.4
1.8 per 100,000
˃70 years 2.3
3.2 per 100,000
doses
Older age
History of thymus disease
undefined
OUTCOME
Died 3 days after admission to
hospital, 9 days after vax
Undiagnosed thymoma
˃
60 years of age
undefined
TIME WITH
TRAVELERS
Discuss the overall risk for travel-
associated YFV disease
High mortality when YFV does
occur
Vaccine requirements per
International Health Regulations
Contraindications or precautions
for vaccination
Risk for serious adverse events
following YF vaccine administration
Personal Protective Measures
Avoid mosquito bites
Proper use of Insect repellent
Wearing permethrin-impregnated
clothing
Staying in accommodations with
screened or air-condition room
Use of bed nets
undefined
REQUIREMENT
International Certificate of
Vaccination or Prophylaxis
Medical Contraindications to
Vaccination
Complete in every detail
Provide a signed and dated letter
on letterhead stationary clearly
stating the contraindication
Signed with official YF stamp
Reasons other than medical
contraindications are not
acceptable for exemption from
vaccination
The medical waiver may not be
accepted by the destination
country
undefined
OTHER TOPICS OF
DISCUSSION
Quarantined for up to 6 days
Requirements are mandatory; to
prevent importation and
transmission of YFV within a given
country
State and territorial health
departments have the authority to
designate nonfederal vaccination
centers and to issue YF vaccination
stamps to those centers
Quarantined (somewhere!)
Denied Entry
Possibly revaccinated at point of
entry (with something!)
The certificate is only valid 10 days
after the vaccine has been
administered
Didn’t get the memo… and the
potential for remuneration
THE DIFFERENCE
ASSESSMENT AND TEACHING
Potential for 3 serious adverse events
Travel consultation
Mosquito prevention
Health insurance while away
Personal Protection
Other health concerns
Diabetes
Heart Disease
AEDES AEGYPTI MOSQUITO
QUESTIONS?
Ana M. Mc Murry Yellow Fever Coordinator   971-673-0301
Jeanine R. Whitney RN, MSN, NHE-C   971-673-0281
Slide Note
Embed
Share

Yellow fever vaccination can lead to severe adverse reactions like anaphylaxis, neurotropic disease, and viscerotropic disease. These reactions can range from immediate hypersensitivity to rare but serious outcomes such as meningitis and multiple system organ failure. The mortality rate associated with yellow fever infection is high, emphasizing the importance of vaccination but also highlighting the risks involved. Travelers need to be aware of the potential adverse events and take necessary precautions.

  • Yellow Fever
  • Adverse Reactions
  • Vaccination Risks
  • Travel Health
  • Travel Precautions

Uploaded on Sep 20, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. YELLOW FEVER What s the difference? WELL -DOCUMENTED ADVERSE REACTIONS

  2. Reported in 2016 1 SEVERE REACTION Immediate Hypersensitivity or Anaphylaxis Adverse reactions to general vaccines: 0.13 per 100,000 doses 33 anaphylaxis reports (25.1 million doses) Reaction time: immediately up to the next day

  3. Reported in 2010: YF Serious adverse events: 4.7 per 100,000 doses distributed 0.8 1.8 anaphylaxis per 100,000 doses 8.3 per 100,000 in 60 years of age 3 SEVERE REACTIONS Immediate Hypersensitivity or Anaphylaxis YEL-AND Vaccine-associated neurotropic disease YEL-AVD Vaccine-associated viscerotropic disease Reaction time: 30 minutes up to 45 days.

  4. VACCINE- ASSOCIATED NEUROTROPIC DISEASE Serious but rarely fatal 1990 2006 29 cases of YF AND 9 meningoencephalitis (neurotropic disease) (5-24 days to onset) 8 Gullain Barr Syndrome (GBS) (7-27 days to onset) 3 Acute Disseminated Encephalomyelitis (ADEM) (7-20 days to onset) 1 Bulbar palsy 8 insufficient data to classify Symptom onset 3 28 days All cases reported in first-time recipients 53 year old male: fatality 9 days post vax . Undiagnosed HIV 56 year old male: longitudinal myelitis. Onset 45 days post vax YEL AND: 0.4 0.8 per 100,000 60 years = 1.6 per 100,000 70 years = 1.1 to 2.3 per 100,000

  5. VACCINE- ASSOCIATED VISCEROTROPIC DISEASE YEL-AVD first described in 2001 Febrile multiple organ system failure that mimics naturally acquired YF 57 cases reported from 14 countries as of Feb 2010. Onset from vaccination 3 days (1-8 days) Time from vaccination to death 10 days (7-30 days) 65% fatality All cases reported in first-time recipients YEL-AVD: 0.3 0.4 per 100,000 doses 60 years 1.4 1.8 per 100,000 70 years 2.3 3.2 per 100,000 doses Older age History of thymus disease

  6. OUTCOME Died 3 days after admission to hospital, 9 days after vax Undiagnosed thymoma 60 years of age www.cdc.gov/mmwr/preview/mmwrhtml/mm6410a5.htm

  7. Discuss the overall risk for travel- associated YFV disease High mortality when YFV does occur Vaccine requirements per International Health Regulations Contraindications or precautions for vaccination Risk for serious adverse events following YF vaccine administration TIME WITH TRAVELERS Personal Protective Measures Avoid mosquito bites Proper use of Insect repellent Wearing permethrin-impregnated clothing Staying in accommodations with screened or air-condition room Use of bed nets

  8. International Certificate of Vaccination or Prophylaxis REQUIREMENT Complete in every detail Provide a signed and dated letter on letterhead stationary clearly stating the contraindication Signed with official YF stamp Medical Contraindications to Vaccination Reasons other than medical contraindications are not acceptable for exemption from vaccination The medical waiver may not be accepted by the destination country

  9. Quarantined for up to 6 days Requirements are mandatory; to prevent importation and transmission of YFV within a given country State and territorial health departments have the authority to designate nonfederal vaccination centers and to issue YF vaccination stamps to those centers OTHER TOPICS OF DISCUSSION Quarantined (somewhere!) Denied Entry Possibly revaccinated at point of entry (with something!) The certificate is only valid 10 days after the vaccine has been administered Didn t get the memo and the potential for remuneration

  10. THE DIFFERENCE ASSESSMENT AND TEACHING AEDES AEGYPTI MOSQUITO Potential for 3 serious adverse events Travel consultation Mosquito prevention Health insurance while away Personal Protection Other health concerns Diabetes Heart Disease

  11. QUESTIONS? Ana M. Mc Murry Yellow Fever Coordinator 971-673-0301 Jeanine R. Whitney RN, MSN, NHE-C 971-673-0281

More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#